The Drug Regulatory Authority of Pakistan (DRAP) is dedicated to enhancing the regulatory framework to meet international standards and elevate the pharmaceutical sector in Pakistan. As part of these efforts, DRAP is aspiring membership of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) for inspectorates in the field of Good Manufacturing Practice (GMP) of drug products.
Pharmaceutical Inspection Co-operation Scheme (PIC/S)
PIC/S is a mutual cooperative arrangement between regulatory authorities in the field of GMP for medicinal products. PIC/S aims to harmonize inspection procedures globally by developing common standards in GMP and facilitating cooperation and networking between competent authorities, regional, and international organizations, thereby increasing mutual confidence.
Virtual Orientation Sessions
To raise awareness in the industry about the PIC/S theme and GMP guidelines, and to facilitate a phased transition towards adopting these guidelines, DRAP will conduct a series of virtual orientation sessions for pharmaceutical manufacturers. The tentative schedule for the first two sessions is as follows, with further sessions to be announced later:
Session | Date |
Session 1 | 4th September, 2024 |
Session 2 | 6th September, 2024 |
![](https://i0.wp.com/www.dra.gov.pk/wp-content/uploads/2024/08/QRCode-for-Orientation-on-PIC_s-GMP-Guidelines-for-the-Pharma-Industry-.png?resize=213%2C213&ssl=1)
Interested participants are required to complete the registration form by 31st August, 2024. The virtual session links will be emailed to registered participants with the session agenda.